Clinical outcomes of AML patients treated with Azacitidine in Portugal: A retrospective multicenter study

Clinical outcomes of AML patients treated with Azacitidine in Portugal: A retrospective multicenter study

Retrospective data was collected from 77 elderly acute myeloid leukemia (AML) patients treated with Azacitidine (AZA) and 50 elderly AML patients treated with intensive chemotherapy (IC) from 4 Portuguese Hospitals. Median OS was 10.6 months in those receiving AZA as 1st line. Response (overall resp...

Full description

Bibliographic Details
Main Authors: António Almeida, Ana Rita Ferreira, Maria João Costa, Sofia Silva, Khalil Alnajjar, Isabel Bogalho, Francesca Pierdomenico, Susana Esteves, Mafalda Alpoim, Gil Braz, Emilia Cortesão, Ricardo Pinto
Format: Article
Language:English
Published: Elsevier 2017-01-01
Series:Leukemia Research Reports
Subjects:
Acute myeloid leukemia
Elderly
Hypomethylating agents
Azacitidine
Online Access:http://www.sciencedirect.com/science/article/pii/S2213048916300486

Internet

http://www.sciencedirect.com/science/article/pii/S2213048916300486

Similar Items